nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—Function kidney decreased—Metformin—polycystic ovary syndrome	0.032	0.101	CcSEcCtD
Morphine—Taste metallic—Metformin—polycystic ovary syndrome	0.022	0.0691	CcSEcCtD
Morphine—UGT1A1—urine—polycystic ovary syndrome	0.0213	0.187	CbGeAlD
Morphine—Appetite absent—Metformin—polycystic ovary syndrome	0.014	0.0442	CcSEcCtD
Morphine—OPRL1—adrenal gland—polycystic ovary syndrome	0.00912	0.08	CbGeAlD
Morphine—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00863	0.0271	CcSEcCtD
Morphine—Rigors—Metformin—polycystic ovary syndrome	0.00856	0.0269	CcSEcCtD
Morphine—UGT1A8—endocrine gland—polycystic ovary syndrome	0.00811	0.0712	CbGeAlD
Morphine—OPRL1—endocrine gland—polycystic ovary syndrome	0.00791	0.0693	CbGeAlD
Morphine—Chest discomfort—Metformin—polycystic ovary syndrome	0.0079	0.0248	CcSEcCtD
Morphine—Accidental injury—Metformin—polycystic ovary syndrome	0.0079	0.0248	CcSEcCtD
Morphine—UGT2B4—endocrine gland—polycystic ovary syndrome	0.00754	0.0662	CbGeAlD
Morphine—UGT1A3—endocrine gland—polycystic ovary syndrome	0.00723	0.0634	CbGeAlD
Morphine—CYP3A4—urine—polycystic ovary syndrome	0.00683	0.0599	CbGeAlD
Morphine—UGT2B15—endocrine gland—polycystic ovary syndrome	0.0068	0.0596	CbGeAlD
Morphine—CYP2D6—urine—polycystic ovary syndrome	0.00672	0.0589	CbGeAlD
Morphine—Lightheadedness—Metformin—polycystic ovary syndrome	0.00625	0.0197	CcSEcCtD
Morphine—Injury—Metformin—polycystic ovary syndrome	0.00552	0.0174	CcSEcCtD
Morphine—Renal impairment—Metformin—polycystic ovary syndrome	0.00533	0.0168	CcSEcCtD
Morphine—Lethargy—Metformin—polycystic ovary syndrome	0.00518	0.0163	CcSEcCtD
Morphine—Dehydration—Metformin—polycystic ovary syndrome	0.00472	0.0148	CcSEcCtD
Morphine—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00468	0.0147	CcSEcCtD
Morphine—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00463	0.0146	CcSEcCtD
Morphine—Breast disorder—Metformin—polycystic ovary syndrome	0.00458	0.0144	CcSEcCtD
Morphine—Cramp muscle—Metformin—polycystic ovary syndrome	0.00457	0.0144	CcSEcCtD
Morphine—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00454	0.0143	CcSEcCtD
Morphine—Abdominal distension—Metformin—polycystic ovary syndrome	0.00441	0.0139	CcSEcCtD
Morphine—Influenza—Metformin—polycystic ovary syndrome	0.00438	0.0138	CcSEcCtD
Morphine—Sweating increased—Metformin—polycystic ovary syndrome	0.00427	0.0134	CcSEcCtD
Morphine—UGT2B7—endocrine gland—polycystic ovary syndrome	0.00415	0.0364	CbGeAlD
Morphine—Drowsiness—Metformin—polycystic ovary syndrome	0.00391	0.0123	CcSEcCtD
Morphine—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.0037	0.0116	CcSEcCtD
Morphine—Bradycardia—Metformin—polycystic ovary syndrome	0.00357	0.0112	CcSEcCtD
Morphine—UGT1A1—endocrine gland—polycystic ovary syndrome	0.00353	0.031	CbGeAlD
Morphine—Rhinitis—Metformin—polycystic ovary syndrome	0.00352	0.0111	CcSEcCtD
Morphine—Hepatitis—Metformin—polycystic ovary syndrome	0.00351	0.011	CcSEcCtD
Morphine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00349	0.011	CcSEcCtD
Morphine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00346	0.0109	CcSEcCtD
Morphine—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00345	0.0108	CcSEcCtD
Morphine—Eye disorder—Metformin—polycystic ovary syndrome	0.00328	0.0103	CcSEcCtD
Morphine—Flushing—Metformin—polycystic ovary syndrome	0.00326	0.0102	CcSEcCtD
Morphine—Angiopathy—Metformin—polycystic ovary syndrome	0.00318	0.01	CcSEcCtD
Morphine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00316	0.00995	CcSEcCtD
Morphine—Chills—Metformin—polycystic ovary syndrome	0.00315	0.0099	CcSEcCtD
Morphine—Malnutrition—Metformin—polycystic ovary syndrome	0.00305	0.00961	CcSEcCtD
Morphine—Erythema—Metformin—polycystic ovary syndrome	0.00305	0.00961	CcSEcCtD
Morphine—Flatulence—Metformin—polycystic ovary syndrome	0.00301	0.00947	CcSEcCtD
Morphine—Dysgeusia—Metformin—polycystic ovary syndrome	0.00299	0.00941	CcSEcCtD
Morphine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00294	0.00924	CcSEcCtD
Morphine—Vision blurred—Metformin—polycystic ovary syndrome	0.00288	0.00906	CcSEcCtD
Morphine—Tremor—Metformin—polycystic ovary syndrome	0.00286	0.009	CcSEcCtD
Morphine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00283	0.00892	CcSEcCtD
Morphine—OPRM1—endocrine gland—polycystic ovary syndrome	0.00278	0.0244	CbGeAlD
Morphine—Malaise—Metformin—polycystic ovary syndrome	0.00275	0.00867	CcSEcCtD
Morphine—Syncope—Metformin—polycystic ovary syndrome	0.00274	0.00862	CcSEcCtD
Morphine—Palpitations—Metformin—polycystic ovary syndrome	0.0027	0.00849	CcSEcCtD
Morphine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00268	0.00845	CcSEcCtD
Morphine—Hypertension—Metformin—polycystic ovary syndrome	0.00264	0.0083	CcSEcCtD
Morphine—Chest pain—Metformin—polycystic ovary syndrome	0.0026	0.00818	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00258	0.00812	CcSEcCtD
Morphine—Discomfort—Metformin—polycystic ovary syndrome	0.00257	0.00808	CcSEcCtD
Morphine—Oedema—Metformin—polycystic ovary syndrome	0.00249	0.00784	CcSEcCtD
Morphine—Infection—Metformin—polycystic ovary syndrome	0.00248	0.00779	CcSEcCtD
Morphine—Shock—Metformin—polycystic ovary syndrome	0.00245	0.00772	CcSEcCtD
Morphine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00245	0.00769	CcSEcCtD
Morphine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00244	0.00768	CcSEcCtD
Morphine—Skin disorder—Metformin—polycystic ovary syndrome	0.00242	0.00762	CcSEcCtD
Morphine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00241	0.00758	CcSEcCtD
Morphine—CYP2C8—endometrium—polycystic ovary syndrome	0.00238	0.0209	CbGeAlD
Morphine—Anorexia—Metformin—polycystic ovary syndrome	0.00238	0.00748	CcSEcCtD
Morphine—Hypotension—Metformin—polycystic ovary syndrome	0.00233	0.00733	CcSEcCtD
Morphine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00227	0.00714	CcSEcCtD
Morphine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00224	0.00704	CcSEcCtD
Morphine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00222	0.00699	CcSEcCtD
Morphine—Somnolence—Metformin—polycystic ovary syndrome	0.00222	0.00697	CcSEcCtD
Morphine—Dyspepsia—Metformin—polycystic ovary syndrome	0.00219	0.0069	CcSEcCtD
Morphine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00217	0.00682	CcSEcCtD
Morphine—CYP2C8—pituitary gland—polycystic ovary syndrome	0.00216	0.0189	CbGeAlD
Morphine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00215	0.00677	CcSEcCtD
Morphine—Fatigue—Metformin—polycystic ovary syndrome	0.00215	0.00676	CcSEcCtD
Morphine—Constipation—Metformin—polycystic ovary syndrome	0.00213	0.00671	CcSEcCtD
Morphine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00205	0.00646	CcSEcCtD
Morphine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00204	0.00641	CcSEcCtD
Morphine—Urticaria—Metformin—polycystic ovary syndrome	0.00198	0.00623	CcSEcCtD
Morphine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00197	0.0062	CcSEcCtD
Morphine—Asthenia—Metformin—polycystic ovary syndrome	0.00179	0.00563	CcSEcCtD
Morphine—CYP2C8—vagina—polycystic ovary syndrome	0.00179	0.0157	CbGeAlD
Morphine—Pruritus—Metformin—polycystic ovary syndrome	0.00176	0.00555	CcSEcCtD
Morphine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00171	0.00537	CcSEcCtD
Morphine—CYP2C8—endocrine gland—polycystic ovary syndrome	0.00167	0.0147	CbGeAlD
Morphine—Dizziness—Metformin—polycystic ovary syndrome	0.00165	0.00519	CcSEcCtD
Morphine—Vomiting—Metformin—polycystic ovary syndrome	0.00159	0.00499	CcSEcCtD
Morphine—Rash—Metformin—polycystic ovary syndrome	0.00157	0.00494	CcSEcCtD
Morphine—Dermatitis—Metformin—polycystic ovary syndrome	0.00157	0.00494	CcSEcCtD
Morphine—Headache—Metformin—polycystic ovary syndrome	0.00156	0.00491	CcSEcCtD
Morphine—ABCB1—embryo—polycystic ovary syndrome	0.00156	0.0137	CbGeAlD
Morphine—Nausea—Metformin—polycystic ovary syndrome	0.00148	0.00466	CcSEcCtD
Morphine—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00128	0.0112	CbGeAlD
Morphine—CYP2D6—female gonad—polycystic ovary syndrome	0.0012	0.0105	CbGeAlD
Morphine—ABCB1—endometrium—polycystic ovary syndrome	0.00114	0.01	CbGeAlD
Morphine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00113	0.00993	CbGeAlD
Morphine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00111	0.00977	CbGeAlD
Morphine—ABCB1—uterus—polycystic ovary syndrome	0.00105	0.00924	CbGeAlD
Morphine—ABCB1—pituitary gland—polycystic ovary syndrome	0.00103	0.00907	CbGeAlD
Morphine—ABCB1—adipose tissue—polycystic ovary syndrome	0.00103	0.00903	CbGeAlD
Morphine—ABCB1—adrenal gland—polycystic ovary syndrome	0.000924	0.0081	CbGeAlD
Morphine—ABCB1—female gonad—polycystic ovary syndrome	0.000861	0.00756	CbGeAlD
Morphine—ABCB1—vagina—polycystic ovary syndrome	0.000856	0.00751	CbGeAlD
Morphine—ABCB1—endocrine gland—polycystic ovary syndrome	0.000801	0.00703	CbGeAlD
Morphine—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	9.37e-05	0.000165	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—GAB1—polycystic ovary syndrome	9.32e-05	0.000164	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	9.29e-05	0.000164	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	9.27e-05	0.000163	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CYP11A1—polycystic ovary syndrome	9.26e-05	0.000163	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SCT—polycystic ovary syndrome	9.2e-05	0.000162	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—TH—polycystic ovary syndrome	9.17e-05	0.000161	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	9.08e-05	0.00016	CbGpPWpGaD
Morphine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	9.08e-05	0.00016	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	9.01e-05	0.000159	CbGpPWpGaD
Morphine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	8.95e-05	0.000158	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—SLC2A4—polycystic ovary syndrome	8.92e-05	0.000157	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—INSR—polycystic ovary syndrome	8.91e-05	0.000157	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	8.83e-05	0.000155	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	8.83e-05	0.000155	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—GNAS—polycystic ovary syndrome	8.8e-05	0.000155	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	8.77e-05	0.000154	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AKR1C3—polycystic ovary syndrome	8.75e-05	0.000154	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PLAT—polycystic ovary syndrome	8.74e-05	0.000154	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—GHRL—polycystic ovary syndrome	8.74e-05	0.000154	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	8.62e-05	0.000152	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CYP17A1—polycystic ovary syndrome	8.61e-05	0.000152	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	8.55e-05	0.000151	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	8.54e-05	0.00015	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	8.48e-05	0.000149	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	8.46e-05	0.000149	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—POMC—polycystic ovary syndrome	8.42e-05	0.000148	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	8.42e-05	0.000148	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—NCOR1—polycystic ovary syndrome	8.39e-05	0.000148	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—CYP19A1—polycystic ovary syndrome	8.39e-05	0.000148	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	8.35e-05	0.000147	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ATF1—polycystic ovary syndrome	8.34e-05	0.000147	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	8.33e-05	0.000147	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PGR—polycystic ovary syndrome	8.25e-05	0.000145	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	8.15e-05	0.000143	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	8.13e-05	0.000143	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	8.1e-05	0.000143	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	8.06e-05	0.000142	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	7.99e-05	0.000141	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	7.98e-05	0.000141	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—CYP1A1—polycystic ovary syndrome	7.95e-05	0.00014	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	7.87e-05	0.000139	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	7.85e-05	0.000138	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—IL6—polycystic ovary syndrome	7.79e-05	0.000137	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	7.76e-05	0.000137	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NGFR—polycystic ovary syndrome	7.7e-05	0.000136	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PLAT—polycystic ovary syndrome	7.67e-05	0.000135	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—GHRL—polycystic ovary syndrome	7.67e-05	0.000135	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—POMC—polycystic ovary syndrome	7.65e-05	0.000135	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PRL—polycystic ovary syndrome	7.63e-05	0.000134	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—INSR—polycystic ovary syndrome	7.53e-05	0.000133	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GNAS—polycystic ovary syndrome	7.49e-05	0.000132	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—TH—polycystic ovary syndrome	7.45e-05	0.000131	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	7.44e-05	0.000131	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—MTHFR—polycystic ovary syndrome	7.41e-05	0.00013	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	7.4e-05	0.00013	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—POMC—polycystic ovary syndrome	7.39e-05	0.00013	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AKT2—polycystic ovary syndrome	7.35e-05	0.000129	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ATF1—polycystic ovary syndrome	7.31e-05	0.000129	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	7.3e-05	0.000129	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	7.3e-05	0.000129	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	7.27e-05	0.000128	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—SLC2A4—polycystic ovary syndrome	7.25e-05	0.000128	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.24e-05	0.000127	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	7.15e-05	0.000126	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	7.13e-05	0.000126	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—NCOR1—polycystic ovary syndrome	7.13e-05	0.000126	CbGpPWpGaD
Morphine—ABCB1—Metabolism—STAR—polycystic ovary syndrome	7.1e-05	0.000125	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	7.1e-05	0.000125	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	7.1e-05	0.000125	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	7.04e-05	0.000124	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	7.01e-05	0.000123	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PGR—polycystic ovary syndrome	6.97e-05	0.000123	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	6.93e-05	0.000122	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.85e-05	0.000121	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CYP19A1—polycystic ovary syndrome	6.81e-05	0.00012	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	6.79e-05	0.00012	CbGpPWpGaD
Morphine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	6.77e-05	0.000119	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—CYP1A1—polycystic ovary syndrome	6.76e-05	0.000119	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NGFR—polycystic ovary syndrome	6.75e-05	0.000119	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—GNAS—polycystic ovary syndrome	6.71e-05	0.000118	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—POMC—polycystic ovary syndrome	6.71e-05	0.000118	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	6.69e-05	0.000118	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PRL—polycystic ovary syndrome	6.69e-05	0.000118	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.65e-05	0.000117	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.49e-05	0.000114	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	6.48e-05	0.000114	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	6.48e-05	0.000114	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AKT2—polycystic ovary syndrome	6.45e-05	0.000113	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.39e-05	0.000113	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	6.35e-05	0.000112	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.35e-05	0.000112	CbGpPWpGaD
Morphine—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	6.33e-05	0.000111	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	6.32e-05	0.000111	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—MTHFR—polycystic ovary syndrome	6.3e-05	0.000111	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NRG1—polycystic ovary syndrome	6.28e-05	0.00011	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	6.24e-05	0.00011	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	6.18e-05	0.000109	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	6.18e-05	0.000109	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GNAS—polycystic ovary syndrome	6.08e-05	0.000107	CbGpPWpGaD
Morphine—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	6.04e-05	0.000106	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	6.03e-05	0.000106	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PPARG—polycystic ovary syndrome	6.01e-05	0.000106	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	6e-05	0.000106	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	5.98e-05	0.000105	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	5.96e-05	0.000105	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	5.96e-05	0.000105	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—POMC—polycystic ovary syndrome	5.93e-05	0.000104	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—INS—polycystic ovary syndrome	5.89e-05	0.000104	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—GNAS—polycystic ovary syndrome	5.88e-05	0.000104	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—NCOR1—polycystic ovary syndrome	5.79e-05	0.000102	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	5.77e-05	0.000102	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	5.77e-05	0.000102	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	5.7e-05	0.0001	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	5.69e-05	0.0001	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	5.67e-05	9.98e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PRL—polycystic ovary syndrome	5.65e-05	9.95e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.61e-05	9.87e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—LHB—polycystic ovary syndrome	5.51e-05	9.69e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	5.51e-05	9.69e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NRG1—polycystic ovary syndrome	5.5e-05	9.69e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CYP1A1—polycystic ovary syndrome	5.49e-05	9.67e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	5.45e-05	9.59e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	5.38e-05	9.47e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	5.38e-05	9.46e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	5.36e-05	9.44e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	5.33e-05	9.39e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—LEP—polycystic ovary syndrome	5.26e-05	9.26e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	5.21e-05	9.18e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	5.19e-05	9.13e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	5.14e-05	9.05e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—MTHFR—polycystic ovary syndrome	5.12e-05	9.01e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PPARG—polycystic ovary syndrome	5.11e-05	9e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	5.07e-05	8.93e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—POMC—polycystic ovary syndrome	5.04e-05	8.87e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—INS—polycystic ovary syndrome	5.01e-05	8.82e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	4.97e-05	8.76e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	4.94e-05	8.69e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	4.91e-05	8.65e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.91e-05	8.64e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	4.88e-05	8.59e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.84e-05	8.52e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	4.84e-05	8.52e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	4.8e-05	8.44e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.74e-05	8.34e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IRS2—polycystic ovary syndrome	4.71e-05	8.3e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	4.69e-05	8.26e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	4.65e-05	8.19e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	4.65e-05	8.18e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—LEP—polycystic ovary syndrome	4.61e-05	8.12e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	4.61e-05	8.11e-05	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—IL6—polycystic ovary syndrome	4.6e-05	8.1e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	4.59e-05	8.07e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	4.53e-05	7.98e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	4.52e-05	7.96e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—POMC—polycystic ovary syndrome	4.52e-05	7.95e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—INS—polycystic ovary syndrome	4.49e-05	7.91e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	4.48e-05	7.88e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	4.38e-05	7.71e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	4.38e-05	7.7e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	4.35e-05	7.65e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	4.34e-05	7.65e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	4.3e-05	7.57e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	4.25e-05	7.48e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	4.22e-05	7.43e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PPARG—polycystic ovary syndrome	4.15e-05	7.31e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.13e-05	7.27e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IRS1—polycystic ovary syndrome	4.11e-05	7.24e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—POMC—polycystic ovary syndrome	4.1e-05	7.21e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—INS—polycystic ovary syndrome	4.07e-05	7.17e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	4.05e-05	7.14e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	4.01e-05	7.06e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	4e-05	7.05e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	3.98e-05	7.01e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—POMC—polycystic ovary syndrome	3.96e-05	6.98e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	3.95e-05	6.95e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—INS—polycystic ovary syndrome	3.94e-05	6.94e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—TH—polycystic ovary syndrome	3.92e-05	6.91e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	3.9e-05	6.86e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—LEP—polycystic ovary syndrome	3.9e-05	6.86e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	3.82e-05	6.72e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IGF1—polycystic ovary syndrome	3.81e-05	6.71e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AKT2—polycystic ovary syndrome	3.81e-05	6.7e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	3.78e-05	6.66e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	3.72e-05	6.55e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	3.72e-05	6.55e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.62e-05	6.37e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	3.59e-05	6.32e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	3.48e-05	6.12e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—TH—polycystic ovary syndrome	3.42e-05	6.02e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	3.39e-05	5.97e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—POMC—polycystic ovary syndrome	3.35e-05	5.9e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—INS—polycystic ovary syndrome	3.33e-05	5.86e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	3.33e-05	5.85e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	3.32e-05	5.85e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	3.32e-05	5.84e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	3.22e-05	5.67e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	3.22e-05	5.67e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	3.22e-05	5.67e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	3.21e-05	5.65e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	3.2e-05	5.64e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	3.13e-05	5.52e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	3.13e-05	5.5e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.06e-05	5.38e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	3.05e-05	5.37e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	2.96e-05	5.2e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	2.95e-05	5.19e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL6—polycystic ovary syndrome	2.91e-05	5.13e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	2.89e-05	5.09e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	2.86e-05	5.04e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.84e-05	5e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	2.79e-05	4.91e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	2.76e-05	4.86e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	2.7e-05	4.75e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	2.66e-05	4.68e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	2.65e-05	4.67e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	2.63e-05	4.63e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	2.62e-05	4.61e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	2.52e-05	4.44e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	2.5e-05	4.41e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.49e-05	4.38e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.47e-05	4.35e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	2.46e-05	4.34e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.43e-05	4.28e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	2.37e-05	4.18e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	2.35e-05	4.14e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	2.21e-05	3.9e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	2.19e-05	3.85e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	2.16e-05	3.8e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—INS—polycystic ovary syndrome	2.14e-05	3.78e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.11e-05	3.71e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.1e-05	3.7e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.05e-05	3.61e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL6—polycystic ovary syndrome	1.96e-05	3.46e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.93e-05	3.39e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	1.9e-05	3.35e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—POMC—polycystic ovary syndrome	1.88e-05	3.31e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—INS—polycystic ovary syndrome	1.87e-05	3.29e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	1.8e-05	3.16e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	1.77e-05	3.12e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	1.76e-05	3.1e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL6—polycystic ovary syndrome	1.72e-05	3.03e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.72e-05	3.03e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.64e-05	2.88e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.55e-05	2.73e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL6—polycystic ovary syndrome	1.46e-05	2.56e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.45e-05	2.55e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.17e-05	2.07e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.16e-05	2.04e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.15e-05	2.03e-05	CbGpPWpGaD
